Ajmaline

Ajmaline

Clinical data
ATC code	C01BA05 (WHO)
Identifiers
CAS Number	4360-12-7
PubChem CID	20367
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H26N2O2
Molar mass	326.433 g/mol

WikiDoc Resources for Ajmaline
Articles
Most recent articles on Ajmaline Most cited articles on Ajmaline Review articles on Ajmaline Articles on Ajmaline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ajmaline Images of Ajmaline Photos of Ajmaline Podcasts & MP3s on Ajmaline Videos on Ajmaline
Evidence Based Medicine
Cochrane Collaboration on Ajmaline Bandolier on Ajmaline TRIP on Ajmaline
Clinical Trials
Ongoing Trials on Ajmaline at Clinical Trials.gov Trial results on Ajmaline Clinical Trials on Ajmaline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ajmaline NICE Guidance on Ajmaline NHS PRODIGY Guidance FDA on Ajmaline CDC on Ajmaline
Books
Books on Ajmaline
News
Ajmaline in the news Be alerted to news on Ajmaline News trends on Ajmaline
Commentary
Blogs on Ajmaline
Definitions
Definitions of Ajmaline
Patient Resources / Community
Patient resources on Ajmaline Discussion groups on Ajmaline Patient Handouts on Ajmaline Directions to Hospitals Treating Ajmaline Risk calculators and risk factors for Ajmaline
Healthcare Provider Resources
Symptoms of Ajmaline Causes & Risk Factors for Ajmaline Diagnostic studies for Ajmaline Treatment of Ajmaline
Continuing Medical Education (CME)
CME Programs on Ajmaline
International
Ajmaline en Espanol Ajmaline en Francais
Business
Ajmaline in the Marketplace Patents on Ajmaline
Experimental / Informatics
List of terms related to Ajmaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Ajmaline is a class Ia antiarrhythmic agent. It is often used to Bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.

The compound was first isolated by Salimuzzaman Siddiqui in 1931 from the roots of Rauwolfia serpentina. He named it Ajmaline, after Hakim Ajmal Khan, one of the most illustrious practitioners of Unani system of medicine in South Asia.

Notes

Template:Antiarrhythmic agents

Template:WikiDoc Sources